National Cancer InstituteU.S. National Institutes of Healthwww.cancer.gov
Center to Reduce Cancer Health Disparities logo

Project Investigator Biography

Roy S. Weiner, M.D. Roy S. Weiner, M.D.

Tulane University
1430 Tulane Ave., SL-68,
New Orleans, LA 70112
phone: (504) 988-6063
fax: (504) 988-6077
email: rweiner@tulane.edu

Dr. Weiner is an associate dean for clinical research and training at Tulane University School of Medicine. In this capacity, he works with center directors and department chairs to enrich Tulane University’s clinical research environment. He also oversees the Master of Science in Clinical Research (MS-CR) program, designed to prepare the next generation of clinical and translational researchers and to transform Louisiana into a destination for clinical research for both patients and the pharmaceutical industry. Previously, Dr. Weiner was founding co-director of the Louisiana Cancer Research Consortium (LCRC), and of the Tulane Cancer Center, as well as the Schlieder Chair. In addition, he has been an associate professor and the chief, Division of Medical Oncology, at the University of Florida, where he was also the American Cancer Society Professorship.

Dr. Roy S. Weiner, through the NCI supported P-20 PACHE Planning grant, is leading an effort to form a Center with Xavier University concentrating on cancer outcome disparities based on race and ethnicity. He is also working with faculty at both Tulane and Xavier to formally incorporate cultural competence into the curriculum of medical (Tulane) and pharmacy (Xavier) students. In addition to his academic responsibilities, Dr. Weiner remains an active cancer clinician and associate director of the LCRC for clinical cancer research.

Dr. Weiner obtained his M.D. from SUNY at Brooklyn. He trained in internal medicine at Johns Hopkins Hospital and at the Hospitals of the University of California in San Francisco. After fellowships at the NIH and l’Institut de Cancerologie et d’Immunogenetique in Villejuif, France, he joined the teaching faculty at Harvard Medical School and was research associate then assistant professor at the Dana Farber Cancer Institute and the Brigham and Women’s Hospital.

View Partnership Abstract Description

Other Project Investigator
Kathleen Kennedy, M.D., M.P.H.
Updated: 04/30/12